The influence of folate pathway polymorphisms on high-dose methotrexaterelated toxicity and survival in children with non-Hodgkin malignant lymphoma

URN:NBN:SI:doc-OP7JC2NN2014Debeljak, MarušaDolžan, VitaErčulj, NinaFaganel, BarbaraJazbec, Janezdocuments/doc/O/URN_NBN_SI_doc-OP7JC2NN_001.pdfdocuments/doc/O/URN_NBN_SI_doc-OP7JC2NN_001.txt348articlestr. 289-292, V1318-209931525337URN:NBN:SI:doc-OP7JC2NNengAssociation of Radiology and OncologyRadiology and oncology (Ljubljana)BYchildhoodne-Hodgkinov limfomnon-Hodgkin lymphomaotroštvopolimorfizempolymorphismThe influence of folate pathway polymorphisms on high-dose methotrexaterelated toxicity and survival in children with non-Hodgkin malignant lymphoma